Efficacy and Safety of GLP-1 medicines for type 2 diabetes and obesity
CrossRef The gynecologic tumor risk related to GLP-1 receptor agonists and SGLT2 inhibitors use: a network meta-analysis of 91 randomized controlled trials Ping-Tao Tseng, Bing-Yan Zeng, Chih-Wei Hsu, Cheuk-Kwan Sun, Mein-Woei Suen, Andre F
After all the positives weve covered, its time for the pendulum to swing a little bit the other way
are maintained at such artificially high levels compared to every other large-market country in the world, restricting demand for brand-name meds but increasing demand for compounded meds
Regularly eating fiber increases GLP-1 secretion due to the short-chain fatty acids produced in the microbiome
Multiple logistic regression was performed to identify whether type 2 diabetes and/or type of surgery were confounding factors in the analysis